All together, these results indicate that there was a possibility SOX2 expression could be used for diagnosing breast cancers, but there was no difference in expression amongst breast cancer types, and therefore it could not be used as specific marker for differentiating TNBC types. This evidence concerns the gene SOX2 and breast carcinoma.